North America is expected to dominate the oncology biosimilars market over the forecast period
On the basis of region, oncology biosimilars market by Coherent Market Insights is segmented
into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North
America is expected to be the dominant market over the forecast period. U.S. FDA approved
first biosimilar in 2015, almost a decade later than first biosimilar approval in Europe.
However, since 2015, the number of approved products has increased rapidly. This is expected
to be factor for growth of the market in North America. Moreover, currently there are number
of products in pipeline, which may receive approval from the FDA over the forecast period. For
instance, Pfizer Inc. — a U.S.-based company — has three biosimilar products (i.e. PF-
05280014, PF-05280586 and PF-06439535) for oncology in Phase 3.
Report includes chapters which deeply display the following deliverable about industry :
• Oncology Biosimilars Market Research Objective and Assumption
• Oncology Biosimilars Market Purview - Report Description, Executive Summary, and Coherent
Opportunity Map (COM)
• Oncology Biosimilars Market Dynamics, Regulations, and Trends Analysis - Market Dynamics,
Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system Launch/Approvals,
Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Oncology Biosimilars Market, By Regions
• Oncology Biosimilars Market Competition by Manufacturers including Production, Share,
Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Oncology Biosimilars Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Oncology Biosimilars Market Manufacturing Cost Analysis including Key Raw Materials and
Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Oncology Biosimilars Market Forecast including Production, Consumption, Import and Export
Forecast by Type, Applications and Region.
• Research Findings and Conclusion